Nuveen’s DexCom DXCM Stock Holding History

Nuveen’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-76,400	Closed	-$6K	–	3207
2022 Q3	$6K	Buy	+76,400	New	+$6.47M	﹤0.01%	3197
2022 Q2	–	Sell	-51,600	Closed	-$6K	–	3312
2022 Q1	$6K	Buy	+51,600	New	+$5.64M	﹤0.01%	3308
2021 Q1	–	Sell	-130,800	Closed	-$12K	–	3378
2020 Q4	$12K	Buy	+130,800	New	+$11.7M	﹤0.01%	3250
2020 Q3	–	Sell	-130,800	Closed	-$13K	–	3308
2020 Q2	$13K	Hold	130,800	–	–	﹤0.01%	3204
2020 Q1	$9K	Hold	130,800	–	–	﹤0.01%	3147
2019 Q4	$7K	Buy	+130,800	New	+$6.2M	﹤0.01%	3180

Other funds holding DXCM

Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.6B AUM 22.09% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Nuveen's DXCM Position: Q3 2026 in Review

Nuveen increased its DexCom (DXCM) stake by 141% in Q3 2026, buying an estimated $215M and bringing the position to 4,411,504 shares worth $381M. The position accounts for 0.09% of the portfolio, ranked #165.

Nuveen first reported a position in DXCM in Q4 2013 and has held it in 49 quarters since. The position peaked at $1.15B in Q3 2021. 604 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

Nuveen held 4,411,504 shares of DexCom worth $381M as of Q3 2026.
Nuveen bought 2,581,269 DexCom shares in Q3 2026, an estimated $215M.
DexCom made up 0.09% of Nuveen's portfolio in Q3 2026, its #165 holding.
Nuveen first reported a position in DexCom in Q4 2013 and has held it in 49 quarters since.
Nuveen's DexCom position peaked at $1.15B in Q3 2021.
604 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.